| EGAD00001004220 |
Samples from Zambia generated for the H3Africa Chip Design Study |
Illumina HiSeq 2500 |
41 |
| EGAD00001004316 |
Samples from Cameroon generated for the H3Africa Chip Design Study |
Illumina HiSeq 2500 |
24 |
| EGAD00001004334 |
Samples from Mali generated for the H3Africa Chip Design Study |
Illumina HiSeq 2500 |
50 |
| EGAD00001004393 |
Samples from Cameroon generated for the H3Africa Chip Design Study |
Illumina HiSeq 2500 |
26 |
| EGAD00001004448 |
Samples from Burkina Faso and Ghana generated for the H3Africa Chip Design Study |
Illumina HiSeq 2500 |
60 |
| EGAD00001004505 |
Samples from Nigeria generated for the H3Africa Chip Design Study |
Illumina HiSeq 2500 |
49 |
| EGAD00001004533 |
Samples from Botswana generated for the H3Africa Chip Design Study |
Illumina HiSeq 2500 |
48 |
| EGAD00001004557 |
Samples from Benin generated for the H3Africa Chip Design Study |
Illumina HiSeq 2500 |
50 |
| EGAD00001005076 |
The TrypanoGEN project was designed in two phases: this dataset is for Phase 1: Variant discovery, and includes 233 samples sequenced to approximately 10X coverage on an Illumina 2500. |
Illumina HiSeq 2500 |
233 |
| EGAD00001005310 |
The phenotypic data for 348 samples of the H3Africa Chip Design Study. |
|
348 |
| EGAD00001006224 |
Whole Exome Sequencing data from a retrospective paediatric HIV-disease progression cohort defined on the World Health Organization's criteria for paediatric HIV progression. Data comprises of BAM and VCF files for 314 participants from 2 countries: Botswana and Uganda. |
Illumina HiSeq 2500 |
314 |
| EGAD00001006244 |
Shotgun metagenomic sequencing data for nasopharyngeal colonization dynamics with Streptococcus pneumoniae and associated antimicrobial-resistance in a South African birth cohort.
https://www.ebi.ac.uk/ena/data/view/PRJEB37312 |
|
196 |
| EGAD00001006295 |
SNPS and INDELS of novel hereditary neurological disease genes in Mali. |
|
10 |
| EGAD00001006418 |
These sequences were sequenced at the Broad on an Illumina HiSeqX at 30x -- PCR Free. The CRAMS and VCF are as produced by Broad. The VCFs produced were generated by the Broad using GATK. |
|
100 |
| EGAD00001006425 |
AWI-Gen Phase 1 Population cross-sectional study of older adults (mostly between 40 and 60 years), men and women. Six study sites in four sub-Saharan African counties. Ghana, Burkina Faso, Kenya and South Africa. ~12,500 participants, some groups are missing data for specific variables. Questionnaire data (demography, health history, family health history, behaviour and infection data); anthropometry; laboratory assays on blood and urine. |
|
12032 |
| EGAD00001006581 |
This is human phenotype data for participants in a gut microbiome study. This data was collected at the same time as the stool samples used for the microbiome component. Participants were also part of the AWI-Gen Phase 1 main study. https://www.ebi.ac.uk/ena/data/view/PRJEB40733 |
|
171 |
| EGAD00010001258 |
Human Cardio Metabochip from AWIGEN study on the interplay between genetic, epigenetic and environmental risk factors for obesity and related cardiometabolic diseases (CMD) in sub-Saharan Africa |
Human Cardio Metabochip |
973 |
| EGAD00010001996 |
The samples were genotyped on the H3Africa array (~2.3M SNPs) using the Illumina FastTrack Sequencing Service2. The default Illumina pipeline was used for the genotype calling (build GRCh37/hg19). The data was converted to PLINK using the h3abionet/h3agwas/call2plink pipeline and QC done using the h3abionet/h3agwas/qc pipeline |
|
10776 |
